Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
A company is trying to unlock a key to aging, in a long-overlooked body part - 2Trump signs bill allowing whole milk to return to school lunches
- 3Inside the cockpit of RAF tanker during defensive mission against Iranian drones
- 4Figure out How to Acquire Rewarding Open Record Rewards
- 5‘More should be done’: UN pushes Syrian regime on justice for Druze, Alawites and minority groups
- How to identify animal tracks, burrows and other signs of wildlife in your neighborhood
- Amateur's Manual for Venture Strategies for Tenderfoots
- How HIV/AIDS got its name − the words Americans used for the crisis were steeped in science, stigma and religious language
- I'm a hypnotherapist who helps day traders who are losing money. Here's why I think hypnosis works.
- The Tradition of Stone: A Gander at Notable Structures Through the Ages
- IDF destroys two-kilometer-long Gaza terror tunnel in Beit Lahiya
- Instructions to Adjust Work, Life, and Seeking after a Web based Advertising Degree
- 2025 Yachting Editors' Choice Awards: Yachts
- Two Indonesian UN peacekeepers killed in explosion in Lebanon
